Gara Jalqabaatti › Kansaar Onnee Triple-Negative
Qorannoo klinikaalii Kansaar Onnee Triple-Negative Ameerikaa Keessatti hirmaatuu
Qorannoo 147 Kansaar Onnee Triple-Negative f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Houston, TXQorannoo 42
- New York City, NYQorannoo 31
- Nashville, TNQorannoo 28
- Los Angeles, CAQorannoo 27
- Boston, MAQorannoo 26
- San Antonio, TXQorannoo 23
- St. Louis, MOQorannoo 21
- Arlington, VAQorannoo 20
- Atlanta, GAQorannoo 20
- Dallas, TXQorannoo 18
- Chicago, ILQorannoo 16
- Columbus, OHQorannoo 16
- Grand Rapids, MIQorannoo 15
- Tampa, FLQorannoo 15
- New Haven, CTQorannoo 15
- Queens, NYQorannoo 15
- Seattle, WAQorannoo 14
- West Valley City, UTQorannoo 13
- Austin, TXQorannoo 13
- San Diego, CAQorannoo 13
- Philadelphia, PAQorannoo 13
- Orlando, FLQorannoo 12
- Durham, NCQorannoo 12
- Denver, COQorannoo 12
- Baltimore, MDQorannoo 12
- Washington, DCQorannoo 11
- Miami, FLQorannoo 11
- Pittsburgh, PAQorannoo 11
- Edison, NJQorannoo 11
- San Francisco, CAQorannoo 11
- Rochester, MNQorannoo 11
- Cleveland, OHQorannoo 10
- Baldwin Park, CAQorannoo 10
- Detroit, MIQorannoo 9
- Oklahoma City, OKQorannoo 9
- Aurora, COQorannoo 9
- Portland, ORQorannoo 9
- Indianapolis, INQorannoo 9
- Jacksonville, FLQorannoo 9
- Salt Lake City, UTQorannoo 9
Naannoon
- AlabamaQorannoo 11
- ArizonaQorannoo 18
- ArkansasQorannoo 3
- CaliforniaQorannoo 53
- ColoradoQorannoo 21
- ConnecticutQorannoo 19
- DelawareQorannoo 3
- Distaarikii KoloombiyaaQorannoo 7
- FloridaQorannoo 47
- GeorgiaQorannoo 26
- IllinoisQorannoo 20
- IndianaQorannoo 13
- IowaQorannoo 8
- KansasQorannoo 5
- KentuckyQorannoo 6
- LouisianaQorannoo 6
- MaineQorannoo 3
- MarylandQorannoo 18
- MassachusettsQorannoo 26
- MichiganQorannoo 28
- MinnesotaQorannoo 17
- MissouriQorannoo 24
- NebraskaQorannoo 6
- NevadaQorannoo 6
- New JerseyQorannoo 20
- New MexicoQorannoo 3
- New YorkQorannoo 46
- North CarolinaQorannoo 21
- OhioQorannoo 29
- OklahomaQorannoo 10
- OregonQorannoo 12
- PennsylvaniaQorannoo 23
- Rhode IslandQorannoo 4
- South CarolinaQorannoo 9
- South DakotaQorannoo 7
- TennesseeQorannoo 31
- TexasQorannoo 59
- UtahQorannoo 23
- VirginiaQorannoo 28
- WashingtonQorannoo 20
- WisconsinQorannoo 7
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07619534A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06270706A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06465069The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04585750A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 19 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06586957177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07189871PRE-ISPY Phase I/II Oncology Platform Program
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT05868226Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT05422794First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT06799065Study of AVZO-021 in Patients With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT05867251Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
Namoota walitti qabaa jira
Umuriin 30 fi ol · Dubartoota · Haaromfame 25-Ful-2026 · NCT02945579Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT04981119A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06841354Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06393374A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06966700Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC
Namoota walitti qabaa jira
Umuriin 18 fi ol · Dubartoota · Haaromfame 25-Ful-2026 · NCT07066189Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05528133A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07229313A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT06618287Intratumoral N17350 in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07339176Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT05983432A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07705334Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07340541A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07020117Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT06353997Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.